Grace Therapeutics, Inc. (GRCE) Earnings History
Net Loss18 years of earnings data (2009–2026) · Currently unprofitable on a TTM basis
Loading earnings history...
Grace Therapeutics, Inc. (GRCE) Earnings Overview
As of June 28, 2026, Grace Therapeutics, Inc. (GRCE) reported trailing twelve-month net income of -$9M, reflecting +58.4% year-over-year growth. The company earned $-0.55 per diluted share over the past four quarters.
Looking at the long-term picture, GRCE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$922,101 in fiscal 2009.
Grace Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), ACAD ($376M net income, 36.5% margin), GRCE has comparable earnings metrics. Compare GRCE vs RARE →
GRCE Earnings vs Peers
Earnings metrics vs comparable public companies
GRCE Historical Earnings Data (2009–2026)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | -$8M | +42.8% | -$11M | $-0.47 | - | - |
| 2025 | -$14M | +21.9% | -$24M | $-1.13 | - | - |
| 2024 | -$17M | +69.6% | -$17M | $-1.83 | - | - |
| 2023 | -$57M | -367.8% | -$71M | $-7.72 | - | - |
| 2022 | -$12M | +60.5% | -$19M | $-2.02 | - | - |
| 2021 | -$31M | +39.1% | -$26M | $-12.59 | -10039.8% | -8377.1% |
| 2020 | -$51M | -29.5% | -$49M | $-28.78 | - | - |
| 2019 | -$39M | -136.4% | -$34M | $-46.58 | - | - |
| 2018 | -$17M | -110.5% | -$15M | $-59.30 | - | - |
| 2017 | -$8M | -69.7% | -$8M | $-34.22 | - | - |
| 2016 | -$5M | -252.4% | -$7M | $-29.48 | -11892.8% | -18096.2% |
| 2015 | -$1M | +87.3% | -$10M | $-9.59 | -440.2% | -3296.7% |
| 2014 | -$10M | -55.0% | -$10M | $-71.28 | -2318.3% | -2156.2% |
| 2013 | -$7M | -3.0% | -$7M | $-43.35 | -951.7% | -963.8% |
| 2012 | -$7M | -112.6% | -$7M | $-47.79 | -62421.6% | -62535.9% |
| 2011 | -$3M | -103.9% | -$3M | $-28.35 | -10591.9% | -10980.3% |
| 2010 | -$2M | -63.6% | -$2M | $-33.66 | - | - |
| 2009 | $-922,101 | - | $-944,474 | $-8.70 | - | - |
Download Data
Export GRCE earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
17+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GRCE — Frequently Asked Questions
Quick answers to the most common questions about buying GRCE stock.
What is GRCE earnings per share (EPS)?
GRCE trailing twelve-month (TTM) diluted EPS is $-0.55, reflecting +58.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2009 to 2026 is available in the table on this page.
What is Grace Therapeutics, Inc.'s net income?
Grace Therapeutics, Inc. (GRCE) trailing twelve-month net income is $-9M as of 2026. Earnings grew +58.4% year-over-year.
Is GRCE profitable?
GRCE is not currently profitable on a TTM basis, reporting a net loss of $-9M. Net margin is N/A. Investors should monitor for a return to profitability.
What is GRCE's earnings growth rate?
GRCE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2009 to 2026.
What are GRCE's profit margins?
Grace Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -11.9%.
Is GRCE growing earnings?
Yes, GRCE earnings are accelerating — EPS growth of +58.4% exceeds the 5-year CAGR of N/A. TTM net income reached $-9M. Earnings momentum is strengthening.
What was GRCE's best earnings year?
Grace Therapeutics, Inc.'s highest annual net income on record is $-922101.00, achieved in fiscal year 2009. Earnings history on this page spans 2009 to 2026 and includes all annual and quarterly figures.
What were GRCE's earnings last quarter?
GRCE's most recent reported quarter was Q4 2026. Net income was $-1M with diluted EPS of $-0.07. For a full breakdown of all quarters, see the quarterly earnings table on this page.